Insider Transactions in Q3 2025 at Ikena Oncology, Inc. (IKNA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2025
|
Jotin Marango Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,630
-29.35%
|
$78,710
$17.16 P/Share
|
|
Jul 28
2025
|
Jotin Marango Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,776
+50.0%
|
-
|
|
Jul 25
2025
|
Jonathan Jian Wang |
BUY
Grant, award, or other acquisition
|
Indirect |
971,173
+50.0%
|
-
|
|
Jul 25
2025
|
Jonathan Jian Wang |
BUY
Grant, award, or other acquisition
|
Direct |
143,832
+50.0%
|
-
|
|
Jul 25
2025
|
Orbimed Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
83,611
+22.51%
|
$167,222
$2.49 P/Share
|
|
Jul 25
2025
|
David P Bonita |
BUY
Open market or private purchase
|
Indirect |
83,611
+22.51%
|
$2,424,719
$29.9 P/Share
|
|
Jul 25
2025
|
David P Bonita |
BUY
Exercise of conversion of derivative security
|
Direct |
379
+50.0%
|
-
|
|
Jul 25
2025
|
Otello Stampacchia |
BUY
Open market or private purchase
|
Indirect |
267,556
+37.03%
|
$7,759,124
$29.9 P/Share
|
|
Jul 25
2025
|
Otello Stampacchia |
BUY
Exercise of conversion of derivative security
|
Direct |
379
+50.0%
|
-
|
|
Jul 25
2025
|
Erin Butler Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,051
+50.0%
|
-
|